Medtronic PLC operates within the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medtronic PLC with three other
medical equipment manufacturers in North America:
sales of $903.92 million
of which 100%
was Automated Blood),
of which 49%
was Healthcare Products).
During the year ended April of 2018, sales at
Medtronic PLC were $29.95 billion.
a very small
increase of 0.8%
versus 2017, when the company's sales were $29.71 billion.
This was the fifth consecutive year of sales increases at Medtronic PLC
(and since 2013, sales have increased a total of 81%).
Sales of Diabetes saw an increase
that was more than double the company's growth rate: sales were up
11.1% in 2018, from
$1.93 billion to $2.14 billion.
Medtronic PLC also saw significant increases in sales in
Cardiovascular Group (up 8.2% to $11.35 billion)
Restrrative Therapies Group (up 5.1% to $7.74 billion)
Not all segments of Medtronic PLC experienced an increase in sales in 2018:
sales of Minimially Invasive Therapies Group fell 12.1% to $8.72 billion.